Digital Workforce, the software robotics automation expert, will publish its Q1 business review on Friday morning. We expect the strong revenue development of last year to have continued in Q1.

The sweeping tariffs announced by President Donald Trump on 02 April 2025 are reshaping global trade, introducing uncertainty, and with trade barriers likely to drive a negative global growth shock. While tariff negotiations are ongoing and subject to significant change in both directions, Gabriel’s production, particularly in Mexico, could be directly affected, with indirect impacts likely to drive a weaker outlook in H2’2024/25 and into 2025/26. The European market, also the largest market, may be somewhat more insulated against tariff impacts, however, we expect the indirect effects, such as higher lending/mortgage rates, can delay the rebound in the real estate and furniture fabrics market conditions, resulting in greater short-term challenges. The increased macro and policy uncertainty may also present an obstacle in the ongoing carve-out process of FurnMaster, a key driver of near-term uncertainty. Despite the long-term outlook remaining solid, with operating leverage to benefit from an eventual market rebound, the tariff-driven uncertainty lead us to reiterate our Reduce recommendation with a revised price target of DKK 130 per share.

Nordea’s credit losses were nearly nonexistent and overall performance remained stable, but the trade war casts a huge cloud of uncertainty. CFO Ian Smith discusses the company’s resilience in a foggy environment in an interview with inderesTV.

Dagens aktienyheder med Gubra og BioPorto A/S

Faron published data on the results of the BEXMAB trial. The treatment responses were still at a good level, which supports the transition to the pivotal phase (Phase III) of the trial and supports the share value.

Bioporto (One-pager): Capital secured via private placement

ExpreS2ion Biotech: Signs Letter of Intent with WuXi Vaccines to initiate technology evaluation of ExpreS2ion’s proprietary production platform ExpreS2™

Dagens aktienyheder med ExpreS2ion Biotechnologies og BioPorto A/S

Enento will report its Q1 results on Friday, April 25 at 12.00 noon EEST. We expect revenue on par with the comparison period and slightly weakening operating profit.

Bioporto: Rettet emission på 25 mio. aktier fuldtegnet

Bioporto: Rettet emission på 25 mio. nye aktier

Mandatum’s investor story relies on two cornerstones: growth in capital-light asset management and the release of balance sheet capital from the with-profit insurance portfolio. Thanks to these factors, Mandatum's profit distribution will continue to be generous going forward, and the stock's expected return is strongly weighted towards dividend yield.

Dagens aktienyheder med Skjern Bank

The March figures for the Swedish clothing market were published this morning. Sales grew by 6.5% from last year.